Effect on maintenance treatment with chidamide for T- cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation A I/II phase, prospective, single center, open lable study.
Phase of Trial: Phase I/II
Latest Information Update: 09 Aug 2018
At a glance
- Drugs Tucidinostat (Primary)
- Indications Hodgkin's disease; Non-Hodgkin's lymphoma; Precursor T-cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 02 May 2018 New trial record